David Jahns serves as a Managing Partner at Galen Partners, a preeminent healthcare growth equity investment firm with a rich history dating back to 1990. With a robust track record of over 70 growth equity investments, David has honed his expertise in healthcare information technology,...
David Jahns serves as a Managing Partner at Galen Partners, a preeminent healthcare growth equity investment firm with a rich history dating back to 1990. With a robust track record of over 70 growth equity investments, David has honed his expertise in healthcare information technology, specialty pharmaceuticals, and MedTech, positioning him as a thought leader in the healthcare venture capital landscape. His deep understanding of the intricacies of healthcare private equity allows him to identify and nurture innovative companies that are poised to transform the industry.
At Galen Partners, David plays a pivotal role in sourcing and executing strategic investments, leveraging his extensive skills in deal sourcing, due diligence, and mergers and acquisitions. His strategic planning acumen enables him to guide portfolio companies through critical growth phases, ensuring they capitalize on market opportunities while navigating the complexities of the healthcare ecosystem. David's leadership is instrumental in fostering collaborative relationships with entrepreneurs and management teams, empowering them to achieve their vision while driving value creation.
Currently, David is spearheading several key projects that focus on IT-enabled services, which are increasingly vital in enhancing operational efficiencies and patient outcomes in healthcare. His commitment to advancing healthcare innovation is complemented by his expertise in private equity and mezzanine financing, allowing him to craft tailored investment strategies that align with the unique needs of each portfolio company. Through his work at Galen Partners, David Jahns continues to make significant contributions to the evolution of healthcare, championing transformative solutions that improve patient care and drive sustainable growth in the sector.
